Data and Statistics on ADHD | Attention-Deficit / Hyperactivity Disorder, Centers for Disease Control and Prevention (2024) Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers, Front Neurosci (2013) Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison, European Child and Adolescent Psychiatry (2017) Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis, PLoS One (2020) FDA approves multiple generics of ADHD and BED treatment, Food and Drug Administration (2023) DailyMed RITALIN- methylphenidate hydrochloride tablet, National Institutes of Health (2025) DailyMed VYVANSE- lisdexamfetamine dimesylate capsule and tablet, National Institutes of Health (2023) How to Switch Stimulants: A Dosing Guide for ADHD, Psychiatric Times (2021) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

They are not drugs, foods, cosmetics, or medical devices, and are not for human or veterinary use
Training consistency and a decent protein intake (1.62.2 g/kg/day) remain the real game changers
Cytoskeletal organization and extracellular matrix interaction studies